Clinical Trials Browser

OTHER × Rectal Neoplasms × Topotecan × Clear all

NCT00215956 2013-12-23

A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma

Phase 1 Completed

Gastrointestinal

Rectal Neoplasms